(MedPage Today) -- The efficacy of golimumab (Simponi) for alleviating the joint and skin symptoms of psoriatic arthritis persisted for 5 years in the long-term extension of a randomized study. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment